![]() AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. | ||
Founding Date | Founding Date 2012 | Founding Date 2003 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Irvine, US HQ Newport Beach, US | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB |
Employees | Employees 6 | Employees 58 |
Financial | ||
Net income | Net income ($39.2m) (FY, 2025) | Net income (£14.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 112.6m | Total funding raised $ 66.8m |

e-therapeutics is a computational drug discovery company.
View company